Target intelligence / Profile preview

BAZ1A antisense RNA 1 (BAZ1A-AS1)

Target
BAZ1A-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

**BAZ1A-AS1** is a long non-coding RNA (lncRNA) transcribed antisense to the BAZ1A (Bromodomain adjacent to zinc finger domain 1A) gene, whose product is involved in chromatin assembly and remodeling[1][5]. Antisense RNAs such as BAZ1A-AS1 often regulate the expression of their corresponding sense genes (such as BAZ1A) either through transcriptional interference, chromatin modification, or direct RNA-RNA interactions. There are no published studies or functional characterizations in the current literature explicitly detailing the molecular or disease roles of BAZ1A-AS1 specifically. Generally, antisense RNAs can modulate sense gene expression, participate in chromatin structure regulation, and may contribute to gene silencing or activation depending on context[6]. As of current knowledge, BAZ1A-AS1 is not known to be a direct therapeutic target, nor have any drugs been developed to modulate its expression or function. **Key clarifications**: - There is no evidence that BAZ1A-AS1 is a protein, receptor, or drug target; it is a lncRNA whose functions are general to the category of antisense RNAs[6]. - The BAZ1A protein itself, not the antisense RNA, is involved in chromatin remodeling and has been implicated in transcriptional regulation, DNA repair, and other nuclear processes[1][4][5]. - This antisense RNA may regulate BAZ1A expression or chromatin state but is not directly actionable as a therapeutic target given current data.

Other names
BAZ1A-AS1BAZ1A antisense RNA 1
02

Mechanism of action

none known

03

Biological functions

Regulation of gene expression (cis or trans regulation of BAZ1A or nearby genes)Chromatin remodeling (by modulating interaction of associated proteins such as BAZ1A)Other, likely context-dependent regulatory RNA functions
04

Disease associations

Limited or uncertain; lncRNAs including other antisense RNAs have reported associations in cancers and other diseases, but BAZ1A-AS1 itself is not yet directly implicated in specific diseases based on current data[6].

Beyond the preview

Go deeper on BAZ1A antisense RNA 1 (BAZ1A-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAZ1A antisense RNA 1 (BAZ1A-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call